Naturalistic examination of the anxiolytic effects of medical cannabis and associated gender and age differences in a Canadian cohort
Abstract Background The aim of the current study was to examine patterns of medical cannabis use in those using it to treat anxiety and to investigate if the anxiolytic effects of cannabis were impacted by gender and/or age. Methods Patient-reported data (n = 184 participants, 61% female, 34.7 ± 8.0...
Main Authors: | Meenu Minhas, Stephanie E. Lunn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | Journal of Cannabis Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42238-023-00192-x |
Similar Items
-
Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
by: Brishna S. Kamal, et al.
Published: (2018-10-01) -
Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial
by: Sukpiriyagul A, et al.
Published: (2023-08-01) -
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01) -
Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
by: Xintian Lyu, BS, et al.
Published: (2023-01-01) -
Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice
by: Nichole Reisdorph, et al.
Published: (2024-03-01)